Manhattan Hospital Partners with Cybin to Provide Psychedelic Therapies to Marginalized Communities
“It’s time for psychedelic medicine to climb down from the ivory tower and into the community,” says Cybin Chief Clinical Officer Dr. Alex Belser.
psilocybin
Jon Stewart ‘Would Love’ to Try Microdosing Psychedelics
The comedian publicly expresses interest in the mental health treatment trend the same day as Paul Stamets’ massive microdosing study results were published.
New Evidence Microdosing Psychedelics Reduces Anxiety and Depression
This study also showed microdosers were less likely to use alcohol and were most likely to abstain from consuming alcohol entirely.
Psychedelic Business Spotlight: November 19
This week in psychedelic business news: Companies partner on new dosage method; MindMed investigates LSD microdosing; Health Canada allows a psilocybin production campus.
DEA Quadruples Psilocybin Manufacturing for Research in Final 2021 Production Quotas
Drug Enforcement Agency also hugely boosts MDMA and DMT quotas “in response to the nationwide public interest in hallucinogenic controlled substances research.”
Animals That Eat Psychedelics and Enjoy the Trip
Is drug use a natural instinct? From mandrils ingesting ibogaine to deer munching on red and white-spotted mushrooms like antlered Super Mario characters, humans aren’t the only mammals that seek out and consume psychoactive substances.
Psychedelic Business Spotlight: November 12
This week in psychedelic business news: two of the biggest players in the industry unveil big data; Numinus Wellness helps MAPS expand MDMA study; and Ketamine One announces IPO intention.
Canada Reaches Psychedelic Milestone with First Legal Group Psilocybin Therapy Session
And the results, according to the participants, were nothing short of “profound.”
Jada Pinkett Smith Reveals Psilocybin Helped Her Overcome ‘Crippling Depression’ in ‘Red Table Talk’ About Psychedelics
Will Smith’s wife, and her son, Jaden, lead a “Red Table Talk” about psychedelics with author Michael Pollan and other guests.
Largest Psilocybin Therapy Trial Ever Conducted Shows Depressive Symptoms Rapidly Reduce
“A single dose of psilocybin generated a rapid response that lasted up to 12 weeks,” explains principal investigator Dr. David J. Hellerstein, who was evaluating Compass Pathways’ novel drug formulation COMP360.
End of content
End of content